FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075153755> ?p ?o ?g. }

• W2075153755 endingPage "827" @default.
• W2075153755 startingPage "820" @default.
• W2075153755 abstract "Cross-linking of specific tumor antigens with the T-cell-associated CD3 and CD28 antigens can increase IL-2 secretion, proliferation and antigen-specific cytotoxicity in resting T cells. This cross-linking can be achieved effectively by bispecific monoclonal antibodies (BiMAb) with specificity for both the tumor antigen and CD3 or CD28 antigen, respectively. To take advantage of the enhanced activation of CD3 pre-activated T cells by additional activation via the CD28 antigen, BiMAb OKT3/HRS-3 with reactivity to both CD3 and the Hodgkin's-lymphoma-associated CD30 antigen and the BiMAb 15E8/ HRS-3 with reactivity to both CD28 and CD30 antigen were generated by hybridoma fusion. Resting T cells, represented by Jurkat cells (CD3+ /CD28+) were specifically activated to produce IL-2 by co-cultivation with an EBV-transformed B-cell line (LAZ509, CD30+/CD19+) only in the presence of the CD30/ CD28 cross-linking BiMAb and an additional cross-linking anti-CD3/CDI9 BiMAb (OKT3/6A4). Neither the cross-linking BiMAbs alone nor any combination of the monospecific parental MAbs induced a comparable IL-2 production by Jurkat cells in the presence of LAZ509. In addition, using a combination of these BiMAbs, an antigen-dependent cytotoxicity was induced by targeting APC-depleted peripheral blood lymphocytes to CD30+ L540 cells. T cells, previously specifically activated by CD3/CD30 in the presence of CD30 antigen, were cytotoxic to CD30+ cell lines only after incubation with BiMAb anti-CD28/ CD30. Neither of the BiMAbs nor any of the parental antibodies induced a comparable effect. Our results indicate that such BiMAbs may offer a new approach for specific immunotherapy of Hodgkin's lymphoma, which takes advantage of cytokine secretion and cytotoxicity of activated T cells." @default.
• W2075153755 created "2016-06-24" @default.
• W2075153755 creator A5003056562 @default.
• W2075153755 creator A5010998605 @default.
• W2075153755 creator A5014979722 @default.
• W2075153755 creator A5023054875 @default.
• W2075153755 creator A5032646587 @default.
• W2075153755 creator A5052238969 @default.
• W2075153755 creator A5061699262 @default.
• W2075153755 creator A5062198465 @default.
• W2075153755 creator A5066528064 @default.
• W2075153755 creator A5075617216 @default.
• W2075153755 creator A5080886176 @default.
• W2075153755 date "1993-07-09" @default.
• W2075153755 modified "2023-10-14" @default.
• W2075153755 title "CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: Potential use for the treatment of hodgkin's lymphoma" @default.
• W2075153755 cites W1965824265 @default.
• W2075153755 cites W1970396539 @default.
• W2075153755 cites W1973498245 @default.
• W2075153755 cites W1975716255 @default.
• W2075153755 cites W1976722345 @default.
• W2075153755 cites W1983267929 @default.
• W2075153755 cites W2000517438 @default.
• W2075153755 cites W2001962695 @default.
• W2075153755 cites W2020426610 @default.
• W2075153755 cites W2024866691 @default.
• W2075153755 cites W2026226010 @default.
• W2075153755 cites W2030522563 @default.
• W2075153755 cites W2043948891 @default.
• W2075153755 cites W2046536971 @default.
• W2075153755 cites W2057073801 @default.
• W2075153755 cites W2065272367 @default.
• W2075153755 cites W2084703695 @default.
• W2075153755 cites W2086857441 @default.
• W2075153755 cites W2091438913 @default.
• W2075153755 cites W2100410983 @default.
• W2075153755 cites W2122624455 @default.
• W2075153755 cites W6875991 @default.
• W2075153755 doi "https://doi.org/10.1002/ijc.2910540517" @default.
• W2075153755 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7686889" @default.
• W2075153755 hasPublicationYear "1993" @default.
• W2075153755 type Work @default.
• W2075153755 sameAs 2075153755 @default.
• W2075153755 citedByCount "31" @default.
• W2075153755 countsByYear W20751537552013 @default.
• W2075153755 countsByYear W20751537552018 @default.
• W2075153755 countsByYear W20751537552023 @default.
• W2075153755 crossrefType "journal-article" @default.
• W2075153755 hasAuthorship W2075153755A5003056562 @default.
• W2075153755 hasAuthorship W2075153755A5010998605 @default.
• W2075153755 hasAuthorship W2075153755A5014979722 @default.
• W2075153755 hasAuthorship W2075153755A5023054875 @default.
• W2075153755 hasAuthorship W2075153755A5032646587 @default.
• W2075153755 hasAuthorship W2075153755A5052238969 @default.
• W2075153755 hasAuthorship W2075153755A5061699262 @default.
• W2075153755 hasAuthorship W2075153755A5062198465 @default.
• W2075153755 hasAuthorship W2075153755A5066528064 @default.
• W2075153755 hasAuthorship W2075153755A5075617216 @default.
• W2075153755 hasAuthorship W2075153755A5080886176 @default.
• W2075153755 hasConcept C114684123 @default.
• W2075153755 hasConcept C147483822 @default.
• W2075153755 hasConcept C148125776 @default.
• W2075153755 hasConcept C153911025 @default.
• W2075153755 hasConcept C154317977 @default.
• W2075153755 hasConcept C159654299 @default.
• W2075153755 hasConcept C167672396 @default.
• W2075153755 hasConcept C179464577 @default.
• W2075153755 hasConcept C185592680 @default.
• W2075153755 hasConcept C202751555 @default.
• W2075153755 hasConcept C203014093 @default.
• W2075153755 hasConcept C2776090121 @default.
• W2075153755 hasConcept C2779338263 @default.
• W2075153755 hasConcept C502942594 @default.
• W2075153755 hasConcept C542903549 @default.
• W2075153755 hasConcept C55493867 @default.
• W2075153755 hasConcept C70905583 @default.
• W2075153755 hasConcept C86803240 @default.
• W2075153755 hasConcept C8891405 @default.
• W2075153755 hasConceptScore W2075153755C114684123 @default.
• W2075153755 hasConceptScore W2075153755C147483822 @default.
• W2075153755 hasConceptScore W2075153755C148125776 @default.
• W2075153755 hasConceptScore W2075153755C153911025 @default.
• W2075153755 hasConceptScore W2075153755C154317977 @default.
• W2075153755 hasConceptScore W2075153755C159654299 @default.
• W2075153755 hasConceptScore W2075153755C167672396 @default.
• W2075153755 hasConceptScore W2075153755C179464577 @default.
• W2075153755 hasConceptScore W2075153755C185592680 @default.
• W2075153755 hasConceptScore W2075153755C202751555 @default.
• W2075153755 hasConceptScore W2075153755C203014093 @default.
• W2075153755 hasConceptScore W2075153755C2776090121 @default.
• W2075153755 hasConceptScore W2075153755C2779338263 @default.
• W2075153755 hasConceptScore W2075153755C502942594 @default.
• W2075153755 hasConceptScore W2075153755C542903549 @default.
• W2075153755 hasConceptScore W2075153755C55493867 @default.
• W2075153755 hasConceptScore W2075153755C70905583 @default.
• W2075153755 hasConceptScore W2075153755C86803240 @default.
• W2075153755 hasConceptScore W2075153755C8891405 @default.
• W2075153755 hasIssue "5" @default.

• next